Omniox, Inc.
PrivateLast Round
Convertible Debt
Mar 30, 2026
Total Funding Raised
$61.57M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Omniox, Inc. is a biopharmaceutical company developing oxygen-delivery therapeutics to treat a range of diseases, including solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omniox, Inc. Comparables
Compare Omniox, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NuvOx Therapeutics | 81% | |
| Prolong Pharmaceuticals, LLC | 80% | |
| Aurum Biosciences Ltd | 73% | |
Omniox, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 30, 2026 | ||||
| Grant | Jan 22, 2024 | ||||
| Early Funding | Nov 1, 2023 | ||||
| Series D | Mar 23, 2018 | ||||
| Grant | Aug 2, 2017 | ||||
Grant | Sep 1, 2016 |
Omniox, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Wavemaker Three-Sixty Health | Early Funding |
| Samsara BioCapital | Early Funding |
| Medical Technology Enterprise Consortium | Grant |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 112% MoM.
- May 17, 2026
Monthly visitors grew 39% MoM.
Omniox, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Omniox, Inc.'s valuation, stock price, and market status.